Taiwan FDA registration d0ea5543ad5adc5cf7678e6dc59e5d32
Lisucon blood glucose measurement system
TW: 利速康血糖量測系統
Taiwan·Risk Class 2·EPS BIO TECHNOLOGY CORP.·Registered Aug 23, 2006 – Aug 23, 2011CancelledRegistration details
- Analysis ID
- d0ea5543ad5adc5cf7678e6dc59e5d32
- Customs Code
- DHY00500217402
Company information
- Manufacturer
- EPS BIO TECHNOLOGY CORP.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- EPS BIO TECHNOLOGY CORP.
Product details
- Intended Use
- Used to measure glucose content in fresh microvascular whole blood samples in vitro.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- import
Dates and status
- Registration Date
- Aug 23, 2006
- Expiry Date
- Aug 23, 2011
- Cancellation Date
- Nov 20, 2012
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Lisucon blood glucose measurement system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number d0ea5543ad5adc5cf7678e6dc59e5d32 and manufactured by EPS BIO TECHNOLOGY CORP.. The authorized representative in Taiwan is EPS BIO TECHNOLOGY CORP..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices